A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...

The NASA Mars Sample Return program is encountering resistance from the planetary science community due to proposed budget language that would terminate the current mission framework. In early January ...

Java ranked third in the Tiobe Index for January 2026 at 8.71%, holding steady behind Python and C and just ahead of C++. Tiobe named C# its Programming Language of the Year for 2025 after the largest ...

Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that the Company has granted Norgine Pharma UK Limited, an affiliate of Norgine, a leading European specialty pharmaceutical company, an exclusive ...

Beginner-friendly Java programs demonstrating Object-Oriented Programming (OOP) concepts such as abstraction, interfaces, class design, and basic system modeling. Includes two core tasks: a Library ...

Over on YouTube, [Ben Eater] pursues that classic 8-bit sound. In this video, [Ben] integrates the MOS Technology 6581 Sound Interface Device (SID) with his homegrown 6502. The 6581 SID was famously ...

The Reactor Pilot Program has its pros, but it needs to be paired with money and action from Congress and the presidency. Last month, the US Department of Energy (DOE) announced the selection of ten ...

When running a Java program in Eclipse IDE that uses Scanner.nextLine() for user input, the console fails to reposition the input cursor correctly after an exception or invalid input. Even though the ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. If you’ve ever searched for information online about the ...

The code generated by large language models (LLMs) has improved some over time — with more modern LLMs producing code that has a greater chance of compiling — but at the same time, it's stagnating in ...

First patient enrolled in ECLIPSE 2 Phase 3 clinical trial evaluating the switch to the combination of tobevibart and elebsiran in patients not achieving undetectable hepatitis delta virus RNA despite ...